Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Equity Average (2016 - 2025)

Avanos Medical's Equity Average history spans 10 years, with the latest figure at $457.8 million for Q3 2024.

  • For Q3 2024, Equity Average fell 20.48% year-over-year to $457.8 million; the TTM value through Sep 2024 reached $457.8 million, down 20.48%, while the annual FY2023 figure was $1.3 billion, 1.34% down from the prior year.
  • Equity Average for Q3 2024 was $457.8 million at Avanos Medical, up from -$171.8 million in the prior quarter.
  • Across five years, Equity Average topped out at $1.3 billion in Q3 2021 and bottomed at -$292.0 million in Q2 2022.
  • The 5-year median for Equity Average is $603.4 million (2024), against an average of $662.6 million.
  • The largest annual shift saw Equity Average skyrocketed 971.03% in 2021 before it crashed 237.43% in 2024.
  • A 5-year view of Equity Average shows it stood at $1.3 billion in 2020, then dropped by 0.56% to $1.3 billion in 2021, then grew by 0.67% to $1.3 billion in 2022, then fell by 3.77% to $1.2 billion in 2023, then crashed by 62.75% to $457.8 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Equity Average are $457.8 million (Q3 2024), -$171.8 million (Q2 2024), and $603.4 million (Q1 2024).